Update on Treatment of Clostridioides difficile Infection

Clostridioides difficile infection (CDI) is the leading cause of health care –associated infections in the United States. The increasing incidence and recurrence rates of CDI together with its associated morbidity and mortality are great concerns. Newer treatment methods, such as narrow-spectrum antibiotics, monoclonal antibodies, and microbial replacement therapies, are b eing developed and implemented. We searched PubMed to identify published literature from 2010 to 2018 using the following keywords: Clostridium difficile, treatment, and therapy.

Source: Mayo Clinic Proceedings - March 31, 2020 Category: Internal Medicine Authors: Janice M. Cho, Darrell S. Pardi, Sahil Khanna Tags: Review Source Type: research